Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Immunity ; 57(8): 1864-1877.e9, 2024 Aug 13.
Article in English | MEDLINE | ID: mdl-39111315

ABSTRACT

Tumor-infiltrating lymphocyte (TIL) hypofunction contributes to the progression of advanced cancers and is a frequent target of immunotherapy. Emerging evidence indicates that metabolic insufficiency drives T cell hypofunction during tonic stimulation, but the signals that initiate metabolic reprogramming in this context are largely unknown. Here, we found that Meteorin-like (METRNL), a metabolically active cytokine secreted by immune cells in the tumor microenvironment (TME), induced bioenergetic failure of CD8+ T cells. METRNL was secreted by CD8+ T cells during repeated stimulation and acted via both autocrine and paracrine signaling. Mechanistically, METRNL increased E2F-peroxisome proliferator-activated receptor delta (PPARδ) activity, causing mitochondrial depolarization and decreased oxidative phosphorylation, which triggered a compensatory bioenergetic shift to glycolysis. Metrnl ablation or downregulation improved the metabolic fitness of CD8+ T cells and enhanced tumor control in several tumor models, demonstrating the translational potential of targeting the METRNL-E2F-PPARδ pathway to support bioenergetic fitness of CD8+ TILs.


Subject(s)
CD8-Positive T-Lymphocytes , Lymphocytes, Tumor-Infiltrating , Mitochondria , Tumor Microenvironment , CD8-Positive T-Lymphocytes/immunology , Animals , Mitochondria/metabolism , Mitochondria/immunology , Mice , Tumor Microenvironment/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Lymphocytes, Tumor-Infiltrating/metabolism , Humans , Mice, Inbred C57BL , Cytokines/metabolism , Signal Transduction , Energy Metabolism , PPAR delta/metabolism , Cell Line, Tumor , Neoplasms/immunology , Glycolysis , Mice, Knockout , Oxidative Phosphorylation
2.
Cell ; 158(1): 54-68, 2014 Jul 03.
Article in English | MEDLINE | ID: mdl-24995978

ABSTRACT

Cells allocate substantial resources toward monitoring levels of nutrients that can be used for ATP generation by mitochondria. Among the many specialized cell types, neurons are particularly dependent on mitochondria due to their complex morphology and regional energy needs. Here, we report a molecular mechanism by which nutrient availability in the form of extracellular glucose and the enzyme O-GlcNAc Transferase (OGT), whose activity depends on glucose availability, regulates mitochondrial motility in neurons. Activation of OGT diminishes mitochondrial motility. We establish the mitochondrial motor-adaptor protein Milton as a required substrate for OGT to arrest mitochondrial motility by mapping and mutating the key O-GlcNAcylated serine residues. We find that the GlcNAcylation state of Milton is altered by extracellular glucose and that OGT alters mitochondrial motility in vivo. Our findings suggest that, by dynamically regulating Milton GlcNAcylation, OGT tailors mitochondrial dynamics in neurons based on nutrient availability.


Subject(s)
Adaptor Proteins, Vesicular Transport/metabolism , Glucose/metabolism , Mitochondria/metabolism , N-Acetylglucosaminyltransferases/metabolism , Animals , Axons/metabolism , Carrier Proteins , Drosophila melanogaster , Gene Knockdown Techniques , Hippocampus/cytology , Hippocampus/metabolism , Humans , Male , Mice , Mice, Inbred C57BL , N-Acetylglucosaminyltransferases/genetics , Rats , Sequence Alignment
3.
Cell ; 147(4): 893-906, 2011 Nov 11.
Article in English | MEDLINE | ID: mdl-22078885

ABSTRACT

Cells keep their energy balance and avoid oxidative stress by regulating mitochondrial movement, distribution, and clearance. We report here that two Parkinson's disease proteins, the Ser/Thr kinase PINK1 and ubiquitin ligase Parkin, participate in this regulation by arresting mitochondrial movement. PINK1 phosphorylates Miro, a component of the primary motor/adaptor complex that anchors kinesin to the mitochondrial surface. The phosphorylation of Miro activates proteasomal degradation of Miro in a Parkin-dependent manner. Removal of Miro from the mitochondrion also detaches kinesin from its surface. By preventing mitochondrial movement, the PINK1/Parkin pathway may quarantine damaged mitochondria prior to their clearance. PINK1 has been shown to act upstream of Parkin, but the mechanism corresponding to this relationship has not been known. We propose that PINK1 phosphorylation of substrates triggers the subsequent action of Parkin and the proteasome.


Subject(s)
Mitochondria/metabolism , Mitochondrial Proteins/metabolism , Protein Kinases/metabolism , Ubiquitin-Protein Ligases/metabolism , rho GTP-Binding Proteins/metabolism , Animals , Drosophila Proteins/chemistry , Drosophila Proteins/metabolism , Drosophila melanogaster , Humans , Mice , Mitochondrial Membranes/metabolism , Mitochondrial Proteins/chemistry , Molecular Sequence Data , Parkinson Disease/metabolism , Phosphorylation , Rats , rho GTP-Binding Proteins/chemistry
4.
Mol Cell ; 69(5): 744-756.e6, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29456190

ABSTRACT

Mitochondrial crista structure partitions vital cellular reactions and is precisely regulated by diverse cellular signals. Here, we show that, in Drosophila, mitochondrial cristae undergo dynamic remodeling among distinct subcellular regions and the Parkinson's disease (PD)-linked Ser/Thr kinase PINK1 participates in their regulation. Mitochondria increase crista junctions and numbers in selective subcellular areas, and this remodeling requires PINK1 to phosphorylate the inner mitochondrial membrane protein MIC60/mitofilin, which stabilizes MIC60 oligomerization. Expression of MIC60 restores crista structure and ATP levels of PINK1-null flies and remarkably rescues their behavioral defects and dopaminergic neurodegeneration. In an extension to human relevance, we discover that the PINK1-MIC60 pathway is conserved in human neurons, and expression of several MIC60 coding variants in the mitochondrial targeting sequence found in PD patients in Drosophila impairs crista junction formation and causes locomotion deficits. These findings highlight the importance of maintenance and plasticity of crista junctions to cellular homeostasis in vivo.


Subject(s)
Drosophila Proteins/metabolism , Mitochondrial Membranes/metabolism , Neurons/metabolism , Protein Serine-Threonine Kinases/metabolism , Animals , Drosophila Proteins/genetics , Drosophila melanogaster , Humans , Mitochondrial Membranes/pathology , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Muscle Proteins/genetics , Muscle Proteins/metabolism , Neurons/pathology , Parkinson Disease/genetics , Parkinson Disease/metabolism , Parkinson Disease/pathology , Phosphorylation/genetics , Protein Kinases/genetics , Protein Kinases/metabolism , Protein Serine-Threonine Kinases/genetics
5.
Rev Cardiovasc Med ; 25(6): 230, 2024 Jun.
Article in English | MEDLINE | ID: mdl-39076329

ABSTRACT

Heart failure (HF) is a complex, life-threatening condition characterized by high mortality, morbidity, and poor quality of life. Despite studies of epidemiology, pathogenesis, and therapies, the rate of HF hospitalization is still increasing due to the growing and aging population and an increase in obesity in relatively younger individuals. It remains a predominant issue in the public health and the global economic burden. Current research has focused on how HF affects the entire range of left ventricular ejection fraction (LVEF), especially the three HF subgroups. This review provides a latest overview of pharmacological and non-pharmacological strategies of these three subgroups (HF with preserved ejection fraction, HF with reduced ejection fraction, and HF with mildly reduced ejection fraction). We summarize conventional therapies, investigate novel strategies, and explore the new technologies such as aortic thoracic stimulation and interatrial shunting devices.

6.
Cell ; 136(1): 163-74, 2009 Jan 09.
Article in English | MEDLINE | ID: mdl-19135897

ABSTRACT

Mitochondria are mobile organelles and cells regulate mitochondrial movement in order to meet the changing energy needs of each cellular region. Ca(2+) signaling, which halts both anterograde and retrograde mitochondrial motion, serves as one regulatory input. Anterograde mitochondrial movement is generated by kinesin-1, which interacts with the mitochondrial protein Miro through an adaptor protein, milton. We show that kinesin is present on all axonal mitochondria, including those that are stationary or moving retrograde. We also show that the EF-hand motifs of Miro mediate Ca(2+)-dependent arrest of mitochondria and elucidate the regulatory mechanism. Rather than dissociating kinesin-1 from mitochondria, Ca(2+)-binding permits Miro to interact directly with the motor domain of kinesin-1, preventing motor/microtubule interactions. Thus, kinesin-1 switches from an active state in which it is bound to Miro only via milton, to an inactive state in which direct binding to Miro prevents its interaction with microtubules. Disrupting Ca(2+)-dependent regulation diminishes neuronal resistance to excitotoxicity.


Subject(s)
Calcium/metabolism , Kinesins/metabolism , Mitochondria/metabolism , Animals , Cell Line , Cells, Cultured , Hippocampus/cytology , Humans , Microtubules/metabolism , Mitochondrial Proteins/chemistry , Mitochondrial Proteins/metabolism , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Neurons/cytology , Neurons/metabolism , Rats
7.
J Nanobiotechnology ; 22(1): 584, 2024 Sep 28.
Article in English | MEDLINE | ID: mdl-39334378

ABSTRACT

Psoriasis is a chronic, relapsing, and refractory immune-mediated skin disease with the etiology and pharmaceutical targets remaining unsatisfactorily addressed. Topical herbal-derived compounds, such as tryptanthrin (Tryp), have been considered as an alternative therapy for psoriasis due to their lower costs and fewer side effects compared to other therapies. However, the effectiveness of topically administered drugs is substantially limited by the thickened pathological skin barrier and the low bioavailability of drugs in the deeper layers of the lesion. Ethosomes, being a novel phospholipid-based vesicle system with high content of ethanol, have been implicated in enhancing topical drug absorption and restoring psoriatic lesions. In this study, taking advantages of ethosomes as a soft and malleable drug carrier, we constructed the Tryp-loaded ethosome (Tryp-ES) through a one-step microfluidics-based technique. The optimal formulation of Tryp-ES was achieved by adding amino-acid-derived surfactant sodium lauroyl glutamate, and Tryp-ES exhibited homogeneous particle size and favorable stability at room temperature. In vitro evaluations showed that Tryp of Tryp-ES could be easily internalized into cells and accumulated in cell nuclei, hence inhibited the abnormally proliferated keratinocytes by inducing apoptosis. In vivo and in vitro assessment using psoritic skin of mice revealed that Tryp-ES had preferred skin retention and permeation of loaded drugs within the initial 1 h of topical administration, which could be attributed to transient disintegrations of cell membranes by ethosomes, thus improved cellular fluidity and permeability. Notably, a synergistic effect of ethosomes and Tryp was found in psoriatic mice. Tryp-ES-treated mice showed substantially ameliorated symptoms of psoriasis and reduced pathological alterations due to hyperplasia, inflammation and angiogenesis, without detectable local or systemic toxicities. Interestingly, lipidomics analysis confirmed that the supplementation of phospholipids, as in the form of ethosome vehicles, was an alterantive strategy to relieve psoriatic pathologies. Taken together, this study provides a novel impact for ethosomal topical delivery of Tryp and underlines their potential as an effective therapy for the management of psoriasis.


Subject(s)
Psoriasis , Quinazolines , Skin Absorption , Skin , Psoriasis/drug therapy , Animals , Mice , Humans , Skin/metabolism , Skin/drug effects , Quinazolines/pharmacology , Quinazolines/pharmacokinetics , Quinazolines/chemistry , Homeostasis/drug effects , Phospholipids/chemistry , Liposomes/chemistry , Drug Carriers/chemistry , Administration, Topical , Keratinocytes/drug effects , Keratinocytes/metabolism , Administration, Cutaneous , Drug Delivery Systems/methods , Lipid Metabolism/drug effects , Male , Mice, Inbred BALB C , HaCaT Cells , Particle Size
8.
Cogn Process ; 25(2): 321-331, 2024 May.
Article in English | MEDLINE | ID: mdl-38421459

ABSTRACT

"Subitizing" defines a phenomenon whereby approximately four items can be quickly and accurately processed. Studies have shown the close association between subitizing and math performance, however, the mechanism for the association remains unclear. The present study was conducted to investigate whether form perception assessed on a serial figure matching task is a potential non-numerical mechanism between subitizing ability and math performance. Three-hundred and seventy-three Chinese primary school students completed four kinds of dot comparison tasks, serial figure matching task, math performance tasks (including three arithmetic computation tasks and math word problem task), and other cognitive tasks as their general cognitive abilities were observed as covariates. A series of hierarchical regression analyses showed that after controlling for age, gender, nonverbal matrix reasoning, and visual tracking, subitizing comparison (subitizing vs. subitizing, subitizing vs. estimation) still contributed to simple addition or simple subtraction but not to complex subtraction ability or math word problem. After taking form perception as an additional control variable, the predictive power of different dot comparison conditions disappeared. A path model also showed that form perception fully mediates the relation between numerosity comparison (within and beyond the subitizing range) and arithmetic performance. These findings support the claim that form perception is a non-numerical cognitive correlate of the relation between subitizing ability and math performance (especially arithmetic computation).


Subject(s)
Mathematics , Humans , Male , Female , Child , Cognition/physiology , Problem Solving/physiology , Mathematical Concepts , Pattern Recognition, Visual/physiology , Aptitude/physiology
9.
Zhongguo Zhong Yao Za Zhi ; 49(2): 431-442, 2024 Jan.
Article in Zh | MEDLINE | ID: mdl-38403319

ABSTRACT

This paper aims to explore the inhibitory effect of Yueju Pills on breast cancer and decipher the underlying mechanism. A total of 92 SPF-grade SD female rats were involved in this study, and 14 of them were randomly selected into control group. The remaining 78 rats were administrated with 7,12-dimethylbenzanthracene(DMBA) by gavage to establish the breast cancer model. The modeled rats were randomized into model, tamoxifen(1.9 mg·kg~(-1)·d~(-1)), and low-and high-dose(17, 34 g·kg~(-1)·d~(-1)) Yueju Pills groups. The mental state, food intake, and activities of the rats were observed daily, and the body weight was measured on alternate days. After 12 weeks of administration, the rats were sacrificed and the tumor weight was measured. The serum estrogen and progeste-rone levels were determined by enzyme-linked immunosorbent assay. The histopathological changes of the breast and tumor were observed by hematoxylin-eosin staining. Western blot was employed to measure the protein levels of glucose transporter 1(GLUT1), lactate dehydrogenase A(LDHA), phosphofructokinase muscle(PFKM), pyruvate kinase isozyme type M2(PKM2), hexokinase 2(HK2), nuclear factor-kappaB(NF-κB), and phosphorylated NF-κB. The intestinal microbiome was examined by 16S rRNA high-throughput sequencing. The results showed that compared with the model group, high and low-dose Yueju Pills showed the tumor inhibition rate of 15.8% and 64.5%, respectively, and the low dose group had stronger inhibitory effect. Compared with the control group, the model group presented elevated the levels of estrogen and progesterone in serum. The administration of Yueju Pills lowered such ele-vation, and the low-dose group showed stronger lowering effect(P<0.05). Compared with the model group, Yueju Pills reduced the glands with increased breast tissue, the degree of breast duct expansion, the number and area of acinar cavity, the secretions, and the layers of mammary epithelial cells. Furthermore, Yueju Pills down-regulated the expression of GLUT1, LDHA, PFKM, PKM2, HK2, and NF-κB(P<0.05) and altered the diversity, composition, structure, and abundance of intestinal flora. The results showed that Yueju Pills could inhibit breast cancer by regulating the secretion of estrogen and progesterone, glycolysis, inflammatory cytokines, and intestinal flora.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene , Neoplasms , Rats , Female , Animals , 9,10-Dimethyl-1,2-benzanthracene/toxicity , NF-kappa B/genetics , Progesterone , Glucose Transporter Type 1 , RNA, Ribosomal, 16S , Estrogens
10.
Nanotechnology ; 33(5)2021 Nov 12.
Article in English | MEDLINE | ID: mdl-34670212

ABSTRACT

Nanotechnology is widely used in targeted drug delivery, but different drug delivery systems need to 're-determine' different synthesis schemes, which greatly limits the further expansion of targeted nanomedicine applications. In this study, we propose a facile and versatile modular stacking strategy to fabricate targeted drug delivery systems to enable tailored designs for patient-specific therapeutic responses. The systems were constructed by a pH-sensitive prodrug module and a mitochondrial targeting module via self-assembly. Using this modular strategy, we successfully prepared two targeting nano-drug delivery systems, TPP-DOX and PK-DOX, where the mitochondrial targeting molecules were triphenylphosphonium (TPP) and 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195), respectively. Confocal laser microscopy and flow cytometry tests revealed that TPP-DOX and PK-DOX exhibited high mitochondria targeting capability and greatly improved the drug retention in drug-resistant cells. The antitumor activity tests showed that the IC50 values of TPP-DOX and PK-DOX in MCF-7/ADR cells were 2.5- and 8.2-fold lower than that of free DOX, respectively. These results indicated that PK was more effective than TPP. The studies on their therapeutic effects on human breast cancer resistant cells verified the feasibility of the modular approach, indicated that the two modular targeted drug delivery systems: (1) retain the drug toxicity and cell-killing effect of the prodrug module, (2) have precise targeting capabilities due to mitochondrial targeting module, (3) enhance drug uptake, reduce drug efflux and reverse the multidrug resistance effect to a certain extent. The results show that modular stacking is a practical, effective and versatile method for preparing targeting drugs with broad application prospects. This study provides an easy approach on preparing customizable targeted drug delivery systems to improve precision therapies.


Subject(s)
Antineoplastic Agents , Drug Delivery Systems/methods , Drug Resistance, Multiple/drug effects , Drug Resistance, Neoplasm/drug effects , Nanomedicine/methods , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Humans , Hydrogen-Ion Concentration , MCF-7 Cells , Mitochondria/metabolism , Neoplasms/metabolism , Prodrugs/chemistry , Prodrugs/pharmacokinetics , Prodrugs/pharmacology
11.
Macromol Rapid Commun ; 42(24): e2100524, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34653283

ABSTRACT

Stemming from unique ring structures, heterocyclic polymers exhibit distinguished electrical, mechanical, and photophysical properties and have been widely used in a variety of important applications. Along with the technological significance are the challenges in their synthesis. Traditional synthetic strategies toward heterocyclic polymers often require the direct attachment of heterocycles to polymer backbones, which are generally limited by the lack of suitable and low-cost heterocyclic monomers, tedious reaction process, difficulties in incorporation of multiple substitutents, etc. Alternatively, in situ construction of heterocyclic polymers via triple-bond based polymerization offers promising prospects. This review summarized the recent progress on polymerizations of triple-bond based monomers including alkynes, nitriles, and isonitriles that can in situ generate heterocyclic polymers. The properties and advanced applications of the derived heterocyclic polymers will also be discussed. Finally, the future perspectives and challenges in this field will be addressed.


Subject(s)
Polymers , Polymerization
12.
Phytochem Anal ; 32(2): 124-128, 2021 Apr.
Article in English | MEDLINE | ID: mdl-31359524

ABSTRACT

INTRODUCTION: Traditional methods to derive experimentally-generated relative correction factors (RCFs) for the quantitative analysis of herbal multi-components by single marker (QAMS) method require reference standards and multiple validations with different instruments and columns, which hampers high throughput implementation. OBJECTIVES: To effectively reduce the application amounts of raw material and provide higher and more stable accuracy, this study aimed to develop a method to computationally generate RCFs of herbal components. MATERIALS AND METHODS: This strategy included the published data collection, calibration curves screening, computer algorithm-based RCFs generation and accuracy validation. RESULTS: Using the in silico approach, we have successfully produced 133 RCFs for the multi-component quantitative analysis of 63 widely used herbs. CONCLUSION: Compared with conventional RCFs, this in silico method would be a low cost and highly efficient way to produce practical RCFs for the QAMS method.


Subject(s)
Drugs, Chinese Herbal , Chromatography, High Pressure Liquid , Computer Simulation
13.
J Cell Mol Med ; 24(1): 772-784, 2020 01.
Article in English | MEDLINE | ID: mdl-31736268

ABSTRACT

SPRY4-intronic transcript 1 has been found in several kinds of cancers, but the role of SPRY4-IT1 in breast cancer stem cells has not been studied. We investigated whether SPRY4-IT1 is involved in the promotion of breast cancer stem cells (BCSCs). We used qRT-PCR to detect the expression of SPRY4-IT1 in MCF-7 cells and MCF-7 cancer stem cells (MCF-7 CSCs). The effects of SPRY4-IT1 on the proliferation and renewal ability of breast cancer cells were investigated by in vitro and in vivo assays (ie in situ hybridization, colony formation assay, sphere formation assay, flow cytometry assay, western blotting, xenograft model and immunohistochemistry). The mechanism of SPPRY4-IT1 as a ceRNA was studied by a dual-luciferase reporter assay and bioinformatic analysis. In our study, SPRY4-IT1 was up-regulated in MCF-7 CSCs compared with MCF-7 cells, and high SPRY4-IT1 expression was related to reduced breast cancer patient survival. Furthermore, SPRY4-IT1 overexpression promoted breast cancer cell proliferation and stemness in vitro and in vivo. In addition, SPRY4-IT1 knockdown suppressed BCSC renewal ability and stemness maintenance in vivo and in vitro. The dual-luciferase reporter assays indicated that SPRY4-IT1 as a sponge for miR-6882-3p repressed transcription factor 7-like 2 (TCF7L2) expression. Taken together, these findings demonstrated that SPRY4-IT1 promotes proliferation and stemness of breast cancer cells as well as renewal ability and stemness maintenance of BCSCs by increasing the expression of TCF7L2 through targeting miR-6882-3p.


Subject(s)
Breast Neoplasms/pathology , Gene Expression Regulation, Neoplastic , MicroRNAs/metabolism , Neoplastic Stem Cells/pathology , RNA, Long Noncoding/genetics , Transcription Factor 7-Like 2 Protein/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Proliferation , Female , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , MicroRNAs/genetics , Neoplastic Stem Cells/metabolism , Transcription Factor 7-Like 2 Protein/genetics , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
14.
Mov Disord ; 35(9): 1502-1508, 2020 09.
Article in English | MEDLINE | ID: mdl-32710675

ABSTRACT

Parkinson's disease (PD) is a debilitating movement disorder, significantly afflicting the aging population. Efforts to develop an effective treatment have been challenged by the lack of understanding of the pathological mechanisms underlying neurodegeneration. We have shown that Miro1, an outer mitochondrial membrane protein, situates at the intersection of the complex genetic and functional network of PD. Removing Miro1 from the surface of damaged mitochondria is a prerequisite for mitochondrial clearance via mitophagy. Parkinson's proteins PINK1, Parkin, and LRRK2 are the molecular helpers to remove Miro1 from dysfunctional mitochondria destined for mitophagy. We have found a delay in clearing Miro1 and initiating mitophagy in postmortem brains and induced pluripotent stem cell-derived neurons from PD patients harboring mutations in LRRK2, PINK1, or Parkin, or from sporadic PD patients with no known mutations. In addition, we have shown that reducing Miro1 by both genetic and pharmacological approaches can correct this Miro1 phenotype and rescue Parkinson's-relevant phenotypes in human neurons and fly PD models. These results suggest that the Miro1 defect may be a common denominator for PD, and compounds that reduce Miro1 promise a new class of drugs to battle PD. We propose to couple this Miro1 phenotype with Miro1-based drug discovery in future therapeutic studies, which could significantly improve the success of clinical trials. © 2020 International Parkinson and Movement Disorder Society.


Subject(s)
Neurology , Parkinson Disease , Aged , Drug Discovery , Humans , Mitophagy , Parkinson Disease/drug therapy , Parkinson Disease/genetics , Protein Kinases , Ubiquitin-Protein Ligases
15.
Pharmacol Res ; 149: 104459, 2019 11.
Article in English | MEDLINE | ID: mdl-31541689

ABSTRACT

Gut microbiota and their metabolites (short-chain fatty acids, SCFAs) are associated with the pathogenesis of rheumatoid arthritis (RA). Total Clematis triterpenoid saponins (CTSs) prepared from Clematis mandshurica Rupr. possess therapeutic benefits for arthritic diseases. However, the poor pharmacokinetic properties of CTSs have obstructed the translation of these natural agents to drugs. Here, we examined the effects of CTSs on arthritis symptoms, gut microbiota and SCFAs in rats with collagen-induced arthritis (CIA). Our results showed that the arthritis index scores of CIA rats treated with CTSs were significantly lower than those of the model group. Most importantly, CTSs moderated gut microbial dysbiosis and significantly downregulated the total SCFA concentration in CIA rats. Compared to the control group, CTSs treatment have no significant side effects on the gut microbiota and SCFA metabolism in normal rats. Two differential analyses (LEfSe and DESeq2) were combined to study the details of the changes in gut microbiome, and twenty-four marker taxa at the genus level were identified via a comparison among control, model and CIA rats treated with high doses of CTSs. In particular, the mostly significantly increased gram-negative (G-) and decreased gram-positive (G+) genera in CIA rats were well restored by CTSs. The observed SCFA concentrations demonstrated that CTSs tend to maintain the balance of the gut microbiota. The data presented herein suggest that CTSs could ameliorate arthritis-associated gut microbial dysbiosis and may be potential adjuvant drugs that could provide relief from the gastrointestinal damage caused as a side effect of commonly used drugs.


Subject(s)
Arthritis, Experimental/drug therapy , Clematis/chemistry , Dysbiosis/prevention & control , Fatty Acids, Volatile/metabolism , Gastrointestinal Microbiome/drug effects , Saponins/therapeutic use , Triterpenes/therapeutic use , Animals , Arthritis, Experimental/microbiology , Dysbiosis/microbiology , Female , Rats , Rats, Wistar , Saponins/isolation & purification , Triterpenes/isolation & purification
16.
Angew Chem Int Ed Engl ; 58(41): 14452-14456, 2019 Oct 07.
Article in English | MEDLINE | ID: mdl-31332913

ABSTRACT

A remarkable enhancement of Raman scattering is achieved by submicrometer-sized spherical ZnO superstructures. The secondary superstructures of ZnO particles with a uniform diameter in the range of 220-490 nm was formed by aggregating ca. 13 nm primary single crystallites. By engineering the superstructure size to induce Mie resonances, leading to an electromagnetic contribution to the SERS enhancement. Meanwhile, a highly efficient charge-transfer (CT) contribution derived from the primary structure of the ZnO nanocrystallites was able to enhance the SERS signals as well. The highest Raman enhancement factor of 105 was achieved for a non-resonant molecule by the synergistic effect of CT and Mie resonances. The Mie resonances scattered near-field effect investigated in the present study provides not only an important guide for designing novel SERS-active semiconductor substrates, but also a coherent framework for modelling the electromagnetic mechanism of SERS on semiconductors.

17.
Acta Neuropathol ; 136(4): 607-620, 2018 10.
Article in English | MEDLINE | ID: mdl-29923074

ABSTRACT

Alpha-synuclein is a component of Lewy bodies, the pathological hallmark of Parkinson's disease (PD), and is also mutated in familial PD. Here, by extensively analyzing PD patient brains and neurons, and fly models, we show that alpha-synuclein accumulation results in upregulation of Miro protein levels. Miro is a motor/adaptor on the outer mitochondrial membrane that mediates mitochondrial motility, and is removed from damaged mitochondria to facilitate mitochondrial clearance via mitophagy. PD patient neurons abnormally accumulate Miro on the mitochondrial surface leading to delayed mitophagy. Partial reduction of Miro rescues mitophagy phenotypes and neurodegeneration in human neurons and flies. Upregulation of Miro by alpha-synuclein requires an interaction via the N-terminus of alpha-synuclein. Our results highlight the importance of mitochondria-associated alpha-synuclein in human disease, and present Miro as a novel therapeutic target.


Subject(s)
Drosophila Proteins/genetics , Mitophagy/genetics , Neurons/pathology , Parkinson Disease/genetics , Parkinson Disease/pathology , alpha-Synuclein/metabolism , rho GTP-Binding Proteins/genetics , Animals , Behavior, Animal , Brain/pathology , Cell Differentiation/genetics , Drosophila melanogaster , Humans , Induced Pluripotent Stem Cells/pathology , Mitochondria/genetics , Mitochondria/metabolism , Movement Disorders/genetics , Movement Disorders/psychology , Mutation/genetics , Nerve Degeneration/genetics , Signal Transduction/genetics , Up-Regulation , alpha-Synuclein/genetics
18.
Nanotechnology ; 27(2): 025302, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26630155

ABSTRACT

Ultrathin alumina membranes (UTAMs) as evaporation masks have been a powerful tool for the fabrication of high-density nanodot arrays and have received much attention in magnetic memory devices, photovoltaics, and nanoplasmonics. In this paper, we report the fabrication of a hierarchical ultrathin alumina membrane (HUTAM) with highly ordered submicro/nanoscale channels and its application as an evaporation mask for the realization of unique non-hexagonal nanodot arrays dependent on the geometrical features of the HUTAM. This is the first report of a UTAM with a hierarchical geometry, breaking the stereotype that only limited sets of nanopatterns can be realized using the UTAM method (with typical inter-pore distance of 100 nm). The fabrication of a HUTAM is discussed in detail. An improved, longer wet etching time than previously reported is found to effectively remove the barrier layer and widen the pores of a HUTAM. A growth sustainability issue brought about by pre-patterning is discussed. Spectral comparison was made to distinguish the UTAM nanodots and HUTAM nanodots. Our results can be an inspiration for more sophisticated applications of pre-patterned anodized aluminum oxide in photocatalysis, photovoltaics, and nanoplasmonics.

19.
J Neurosci ; 33(45): 17560-8, 2013 Nov 06.
Article in English | MEDLINE | ID: mdl-24198346

ABSTRACT

The fruit fly Drosophila melanogaster has been established as a premier experimental model system for neuroscience research. These organisms are genetically tractable, yet their nervous systems are sufficiently complex to study diverse processes that are conserved across metazoans, including neural cell fate determination and migration, axon guidance, synaptogenesis and function, behavioral neurogenetics, and responses to neuronal injury. For several decades, Drosophila neuroscientists have taken advantage of a vast toolkit of genetic and molecular techniques to reveal fundamental principles of neuroscience illuminating to all systems, including the first behavioral mutants from Seymour Benzer's pioneering work in the 1960s and 1970s, the cloning of the first potassium channel in the 1980s, and the identification of the core genes that orchestrate axon guidance and circadian rhythms in the 1990s. Over the past decade, new tools and innovations in genetic, imaging, and electrophysiological technologies have enabled the visualization, in vivo, of dynamic processes in synapses with unprecedented resolution. We will review some of the fresh insights into synaptic development, function, and plasticity that have recently emerged in Drosophila with an emphasis on the unique advantages of this model system.


Subject(s)
Drosophila/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Synapses/physiology , Animals , Behavior, Animal/physiology , Neurogenesis/physiology
20.
Biochim Biophys Acta ; 1833(1): 184-94, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22548961

ABSTRACT

Cells precisely regulate mitochondrial movement in order to balance energy needs and avoid cell death. Neurons are particularly susceptible to disturbance of mitochondrial motility and distribution due to their highly extended structures and specialized function. Regulation of mitochondrial motility plays a vital role in neuronal health and death. Here we review the current understanding of regulatory mechanisms that govern neuronal mitochondrial transport and probe their implication in health and disease. This article is part of a Special Issue entitled: Mitochondrial dynamics and physiology.


Subject(s)
Mitochondria/physiology , Movement/physiology , Neurons/physiology , Animals , Biological Transport/physiology , Disease/etiology , Humans , Mitochondria/metabolism , Mitochondrial Dynamics/physiology , Models, Biological , Neurons/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL